Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07148232

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

About this study

PRIMARY OBJECTIVES:

I. Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up.

II. Use expired carbon monoxide (CO) to confirm self-reports of abstinence using a cut-off of CO ≤5 parts per million (ppm).

SECONDARY OBJECTIVES:

I. Biochemically-verified 7-day point prevalence tobacco abstinence at 3-months follow-up.

II. Measured at 6-months follow-up, a total number of expired carbon monoxide (CO-negative samples).

III. Measured at 6-months follow-up, longest duration of abstinence (i.e., total number of uninterrupted days abstinent), proportion with 50% reduction in expired CO for those who do not quit smoking.

IV. Use expired CO to confirm self-reports of abstinence using a cut-off of CO ≤5 ppm.

OUTLINE:

Participants will be randomized to one of two groups:

  • Intervention group receives 6 months of pharmacist consultation, monthly delivery of nicotine replacement therapy, and telephone wellness coaching.
  • Control group receives pharmacist consultation and monthly delivery of nicotine replacement therapy for 3 months.

Participants will be followed up at 1, 3 and 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Able to understand study procedures and to comply with them for the entire length of the study.
  • Ability of individual to understand a written informed consent document, and the willingness to sign it.
  • Staying at the recruitment site and meeting criteria for homelessness as defined by the Homeless Emergency and Rapid Transition to Housing Act.
  • Current smoking (smoking at least 5 cigarettes per day (cpd), verified via expired carbon monoxide (CO) >= 8 ppm using Micro+pro Smokerlyzer).
  • Having an intention to quit smoking within the next six months.
  • English speaking.

Exclusion criteria

  • Contraindication to any study-related procedure or assessment.
  • Reasons that preclude the use of nicotine replacement therapy (NRT) (e.g., pregnancy or myocardial infarction in the past two weeks).

Treatment and study plan

Nicotine replacement therapy (NRT)

Drug

NRT will be administered as patch (transdermal), gum, or lozenge

Other names: NRT

Wellness Coaching

Behavioral

Delivered via phone call

Primary outcomes

  1. Percentage of participants who attended coaching sessions

    Time frame: up to 6 months

    The percentage of participants who attended at least 75% or 7 of the 14 coaching sessions will be reported.

  2. Percentage of participants who used nicotine replacement therapy (NRT)

    Time frame: up to 6 months

    The percentage of participants who used at least 75% will adhere to using NRT for at least half of the treatment duration will be reported.

  3. 7-day point prevalence tobacco abstinence at month 6

    Time frame: 6 months

    Biochemically verified 7-day point prevalence tobacco abstinence at 6-months follow-up will be reported.

Secondary outcomes

  1. 7-day point prevalence tobacco abstinence at month 3

    Time frame: 3 months

    Biochemically verified 7-day point prevalence tobacco abstinence at 3-months follow-up will be reported.

Study contacts

Contact information is provided by the study sponsor or research team.

Jessica Alway

CONTACT

[email protected]

877-827-3222

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • Tobacco Related Disease Research Program

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Aug 29, 2025
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.